Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Clinical trial NCT01344876 · COMPLETED

Trial details

NCT number: NCT01344876
Sponsor: Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma Non-Hodgkin Lymphoma Acute Myeloid Leukemia Acute Lymphoid Leukemia Chronic Myeloid Leukemia

Start date: 2011-04-01
Primary completion: 2014-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.